California State Teachers Retirement System (CalSTRS)’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Other funds holding DSGN
SOCM
RCM
BBA
LGM
DCM
VC
AC
VCM
California State Teachers Retirement System (CalSTRS)'s DSGN Position: Q1 2026 in Review
California State Teachers Retirement System (CalSTRS) reduced its Design Therapeutics (DSGN) stake by 12% in Q1 2026, selling an estimated $1.81K and leaving 1,292 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2563.
California State Teachers Retirement System (CalSTRS) first reported a position in DSGN in Q2 2021 and has held it in 19 quarters since. The position peaked at $370K in Q2 2021. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) held 1,292 shares of Design Therapeutics worth $13.7K as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) sold 179 Design Therapeutics shares in Q1 2026, an estimated $1.81K.
- Design Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2563 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in Design Therapeutics in Q2 2021 and has held it in 19 quarters since.
- California State Teachers Retirement System (CalSTRS)'s Design Therapeutics position peaked at $370K in Q2 2021.
- 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.